Arl13b Regulates Breast Cancer Cell Migration and Invasion by Controlling Integrin-Mediated Signaling
Autor: | Pedro Castanheira, Inês C. Ferreira, Cristina Casalou, Andreia Ferreira, Alexandra Faustino, Ana Félix, José S. Ramalho, Daniela Vaqueirinho, Teresa Barona, Jacinta Serpa, Duarte C. Barral, Fernanda Silva |
---|---|
Přispěvatelé: | Centro de Estudos de Doenças Crónicas (CEDOC), NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) |
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Integrins Cancer Research actin cytoskeleton cell-extracellular matrix adhesion Cell Cancer progression Arl proteins Biology lcsh:RC254-282 Article Metastasis Focal adhesion 03 medical and health sciences 0302 clinical medicine Breast cancer SDG 3 - Good Health and Well-being medicine Cell adhesion Actin cytoskeleton Cancer medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens cancer progression 3. Good health 030104 developmental biology medicine.anatomical_structure Oncology 030220 oncology & carcinogenesis Cancer cell Cancer research integrins arl proteins Cell-extracellular matrix adhesion |
Zdroj: | Cancers, Vol 11, Iss 10, p 1461 (2019) Cancers Volume 11 Issue 10 Repositório Científico de Acesso Aberto de Portugal Repositório Científico de Acesso Aberto de Portugal (RCAAP) instacron:RCAAP |
ISSN: | 2072-6694 |
Popis: | Breast cancer is the first cause of cancer-related mortality among women worldwide, according to the most recent estimates. This mortality is mainly caused by the tumors&rsquo ability to form metastases. Cancer cell migration and invasion are essential for metastasis and rely on the interplay between actin cytoskeleton remodeling and cell adhesion. Therefore, understanding the mechanisms by which cancer cell invasion is controlled may provide new strategies to impair cancer progression. We investigated the role of the ADP-ribosylation factor (Arf)-like (Arl) protein Arl13b in breast cancer cell migration and invasion in vitro, using breast cancer cell lines and in vivo, using mouse orthotopic models. We show that Arl13b silencing inhibits breast cancer cell migration and invasion in vitro, as well as cancer progression in vivo. We also observed that Arl13b is upregulated in breast cancer cell lines and patient tissue samples. Moreover, we found that Arl13b localizes to focal adhesions (FAs) and interacts with &beta 3-integrin. Upon Arl13b silencing, &beta 3-integrin cell surface levels and FA size are increased and integrin-mediated signaling is inhibited. Therefore, we uncover a role for Arl13b in breast cancer cell migration and invasion and provide a new mechanism for how ARL13B can function as an oncogene, through the modulation of integrin-mediated signaling. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |